It Is Time to Reconsider the Blood Pressure Targets in Patients With Type 2 Diabetes?
暂无分享,去创建一个
[1] P. Whelton,et al. Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations. , 2022, Journal of the American College of Cardiology.
[2] G. Reboldi,et al. Benefits of more intensive versus less intensive blood pressure control. Updated trial sequential analysis. , 2022, European journal of internal medicine.
[3] I. V. Van Gelder,et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2021, European heart journal.
[4] Qifu Li,et al. Standards of medical care for type 2 diabetes in China 2019 , 2019, Diabetes/metabolism research and reviews.
[5] G. Lip,et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.
[6] P. Whelton,et al. Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis , 2017, JAMA cardiology.
[7] Lawrence A Leiter,et al. Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. , 2017, The Canadian journal of cardiology.
[8] V. Fuster. No Such Thing as Ideal Blood Pressure: A Case for Personalized Medicine. , 2016, Journal of the American College of Cardiology.
[9] K. Rahimi,et al. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. , 2015, JAMA.
[10] Lawrence A Leiter,et al. Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis. , 2012, Archives of internal medicine.
[11] G. Lyman,et al. The strengths and limitations of meta-analyses based on aggregate data , 2005, BMC Medical Research Methodology.
[12] Belgium.,et al. Global guideline for type 2 diabetes. , 2014, Diabetes research and clinical practice.